ERBB2 and aneurysmal bone cyst: In order to improve the evaluation of the potential role of sorafenib in combination with known effective palliative treatments for HER2-negative ABC, a meta-analysis was conducted to assess the efficacy and safety of sorafenib treatment in patients with HER2-negative ABC.